Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers

HPB

Volumn 12, Issue 4, 2010, Pages 250-261

  Steenks, Mathilde ^a   Van Baal, Mark C P M ^a   Nieuwenhuijs, Vincent B ^b   De Bruijn, Menno T ^a   Schiesser, Marc ^a   Teo, Mike H ^c   Callahan, Tom ^a   Padbury, Rob T A ^a   Barritt, Greg J ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Bile flow; Intermittent ischaemia; Ischaemia reperfusion injury; Ischaemic preconditioning; Lipid; Liver; Obese; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CALCIUM; CREATININE; GLUCOSE; LACTATE DEHYDROGENASE; POTASSIUM; UREA; BIOLOGICAL MARKER; ELECTROLYTE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE FLOW; CALCIUM BLOOD LEVEL; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; FATTY LIVER; GLUCOSE BLOOD LEVEL; INTERMITTENT ISCHEMIA; ISCHEMIC PRECONDITIONING; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER CELL DAMAGE; LIVER FUNCTION; LIVER HISTOLOGY; LIVER ISCHEMIA; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; REPERFUSION; TRANSMISSION ELECTRON MICROSCOPY; UREA BLOOD LEVEL; ANIMAL; BILE; BLOOD; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; LIPID METABOLISM; LIVER; METABOLISM; OBESITY; PATHOPHYSIOLOGY; REPERFUSION INJURY; TIME; ULTRASTRUCTURE; ZUCKER RAT;

ALANINE TRANSAMINASE; ANIMALS; BILE; BIOLOGICAL MARKERS; CALCIUM; DISEASE MODELS, ANIMAL; ELECTROLYTES; FATTY LIVER; ISCHEMIC PRECONDITIONING; LIPID METABOLISM; LIVER; MALE; OBESITY; RATS; RATS, ZUCKER; REPERFUSION; REPERFUSION INJURY; TIME FACTORS;

EID: 77953601204     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00160.x     Document Type: Article

References (48)

1. Ben-Ari Z, Pappo O, Mor E. (2003) Intrahepatic cholestasis after liver transplantation. Liver Transplant 9:1005-1018.
2. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. (2005) The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: A review. Liver Transplant 11:1031-1047.
3. Selzner N, Rudiger H, Graf R, Clavien PA. (2003) Protective strategies against ischemic injury of the liver. Gastroenterol 125:917-936.
4. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2:292-298.
5. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V et al. (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238:843-850.
6. Smyrniotis V, Farantos C, Kostopanagiotou G, Arkadopoulos N. (2005) Vascular control during hepatectomy: Review of methods and results. World J Surg 29:1384-1396.
7. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE et al. (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62:1246-1251.
8. Koneru B, Dikdan G. (2002) Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 73:325-330.
9. Nocito A, El-Badry AM, Clavien PA. (2006) When is steatosis too much for transplantation? J Hepatol 45:494-499.
10. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. (2007) Use of severely steatotic grafts in liver transplantation: A matched case-control study. Ann Surg 246:940-946.
11. Xu C, Yu C, Li Y. (2008) Current studies on therapeutic approaches for ischemia/reperfusion injury in steatotic livers. Hepatol Res 38:851-859.
12. Jaeschke H. (2003) Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol - Gastrointest Liver Physiol 284:G15-G26. (Pubitemid 36076246)
13. Koneru B, Reddy MC, dela Torre AN, Patel D, Ippolito T, Ferrante RJ. (1995) Studies of hepatic warm ischemia in the obese zucker rat. Transplantation 59:942-946.
14. Selzner M, Clavien PA. (2001) Fatty liver in liver transplantation and surgery. Sem Liver Dis 21:105-113.
15. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. (2000) Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 32:1280-1288.
16. Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA. (2006) Mouse livers with macrosteatosis are more susceptible to normo- thermic ischemic injury than those with microsteatosis. J Hepatol 44:694-701.
17. Massip-Salcedo M, Rosello-Catafau J, Prieto J, Avila MA, Peralta C. (2007) The response of the hepatocyte to ischemia. Liver Internat 27:6-16.
18. Nieuwenhuijs VB, De Bruijn MT, Padbury RT, Barritt GJ. (2006) Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci 51:1087-1102.
19. Carrasco-Chaumel E, Rosello-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A et al. (2005) Adenosine monophosphate-activated protein kinase and nitric oxiDe in rat steatotic liver transplantation. J Hepatol 43:997-1006.
20. Koti RS, Yang W, Glantzounis G, Quaglia A, Davidson BR, Seifalian AM. (2005) Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis. Clin Sci 108:55-63.
21. Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, Bartrons R, Ben Mosbah I, Serafin A et al. (2006) Heat shock proteins and mitogenactivated protein kinases in steatotic livers undergoing ischemiareperfusion: Some answers. Am J Pathol 168:1474-1485.
22. Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF et al. (2005) Ischemic preconditioning improves energy state and transplantation survival in obese zucker rat livers. Anes Analg 101:1577-1583.
23. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. (2002) Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 161:587-601.
24. Teoh NC, Farrell GC. (2003) Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 18:891-902.
25. Jourdan M, Vaubourdolle M, Cynober L, Aussel C. (2004) Effect of aging on liver functions-an experimental study in a perfused rat liver model. Exper Gerontol 39:1341-1346.
26. Accatino L, Pizarro M, Solis N, Arrese M, Koenig CS. (2003) Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat. Liver Transplantation 9:1199-1210.
27. Koeppel TA, Trauner M, Mennone A, Arrese M, Rios-Velez L, Boyer JL. (1998) Role of glutathione in hepatic bile formation during reperfusion after cold ischemia of the rat liver. J Hepatol 28:812-819.
28. Bowers BA, Branum GD, Rotolo FS, Watters CR, Meyers WC. (1987) Bile flow - an index of ischemic injury. J Surg Res 42:565-569.
29. Kamiike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. (1988) Adenine nucleotiDe metabolism and its relation to organ viability in human liver transplantation. Transplantation 45:138-143.
30. Sumimoto K, Inagaki K, Yamada K, Kawasaki T, Dohi K. (1988) Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate level. Transplantation 46:506-509.
31. Schiesser M, Wittert A, Nieuwenhuijs VB, Morphett A, Padbury RT, Barritt GJ. (2009) Intermittent ischemia but not ischemic preconditioning is effective in restoring bile flow after ischemia reperfusion injury in the livers of aged rats. J Surg Res 152:61-68.
32. Nieuwenhuijs VB, De Bruijn MT, Schiesser M, Morphett A, Padbury RT, Barritt GJ. (2007) Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia reperfusion injury. Dig Dis Sci 52:1159-1167. (Pubitemid 46626183)
33. Greenhouse DD, Hansen CT, Michaelis OE. (1990) Development of fatty and corpulent rat strains. Inst Lab Anim Res J 32:2-4.
34. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ et al. (1996) Leptin receptor missense mutation in the fatty zucker rat. Nat Genet 13:18-19.
35. Johnson PR, Stern JS, Horwitz BA, Harris RE Jr, Greene SF. (1997) Longevity in obese and lean male and female rats of the zucker strain: Prevention of hyperphagia. Am J Clin Nutr 66:890-903.
36. Hasselgren PO, Fornander J, Jagenburg R, Sundstrom E. (1982) Effects of live ischemia on hepatic protein synthesis in vitro and in vivo. Acta Physiol Scand 114:143-148.
37. Pizarro M, Balasubramaniyan N, Solis N, Solar A, Duarte I, Miquel JF et al. (2004) Bile secretory function in the obese zucker rat: Evidence of cholestasis and altered canalicular transport function. Gut 53:1837-1843.
38. VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. (2001) Impaired biliary lipid secretion in obese zucker rats: Leptin promotes hepatic cholesterol clearance. Am J Physiol - Gastrointest Liver Physiol 281:G393-G404.
39. Peters J, Nieuwenhuijs VB, Morphett A, Porte RJ, Padbury RTA, Barritt GJ. (2010) Increasing cycles of intermittent ischemia can effectively maintain liver function during the acute phase of ischemia reperfusion injury by promotion of bile flow and reduction in bile salt toxicity. Dig Surg 26:455-464.
40. Guo Y, Walther TC, Rao M, Stuurman N, Goshima G, Terayama K et al. (2008) Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 453:657-661.
41. Heijnen BH, Van Veen SQ, Straatsburg IH, Van Gulik TM. (2001) Pronounced effect of minor changes in body temperature on ischemia and reperfusion injury in rat liver. J Appl Physiol 91:265-268.
42. Heiman J, Wallin M, Gustafsson BI, Friman S, Delbro D. (2006) Pharmacological preconditioning of rat liver by up-regulation of heme oxygenase 1. Transplant Proc 38:2705-2707.
43. Burtis CA, Ashwood ER. (1999) Tietz Textbook of Clinical Chemistry. Philadelphia: W.B. Saunders, p. 641.
44. Suzuki S, Inaba K, Konno H. (2008) Ischemic preconditioning in hepatic ischemia and reperfusion. Curr Opin Organ Transplant 13:142-147.
45. Zhong Z, Ramshesh VK, Rehman H, Currin RT, Sridharan V, Theruvath TP et al. (2008) Activation of the oxygen-sensing signal cascaDe prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am J Physiol - Gastrointest Liver Physiol 295:G823-G832.
46. Hoekstra H, Tian Y, Jochum W, Stieger B, Graf R, Porte RJ et al. (2008) Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation 85:1159-1166.
47. Wagner M, Zollner G, Trauner M. (2008) Ischemia and cholestasis: More than (just) the bile ducts! Transplantation 85:1083-1085.
48. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M et al. (2008) A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 248:909-918.